In a very recent study, we documented the identification as well as the characterization of a whole new atypical opioid receptor with distinctive adverse regulatory properties in direction of opioid peptides.1 Our outcomes showed that ACKR3/CXCR7, hitherto known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is https://johne504hhb5.bcbloggers.com/profile